NIHR PHR Bulletin Autumn 2016

The latest bulletin from NIHR

Latest Funding Opportunities 

Commissioned workstream
We currently have funding opportunities open in the following topic areas.
  • 16/39 - Mid-life and physical exercise
  • 16/40 - Preventing road injuries
  • 16/41 - Sedentary behaviour
  • 16/50 - Sun exposure

The application deadline for the above topics is 1pm, 5 December 2016.

  • 16/121 - Healthy diet in early years
  • 16/122 - Interventions in community organisations
  • 16/123 - Migrant health and wellbeing
  • 16/124 - Age-friendly environments

The application deadline for the above topics is 1pm, 25 April 2017.
 

Full details including guidance are available on the NIHR website.

Researcher-led workstream
We are accepting outline applications to our researcher-led workstream. Applications must be within the remit of the PHR Programme.

The deadline for applications is 1pm, 21 November 2016.For more information about this funding opportunity, please visit our website.

Latest news

NIHR committed to push the pace of research
It takes on average 17 years for a promising medicine, being developed in a laboratory to being patient ready, and we think that around 10 years of this is within the NIHR research pathway. As part of the wider commitment to a culture of continuous improvement, the NIHR is committed to reducing this pathway by 20 months. Read the full article.

No evidence of reduction in accidents following M74 motorway extension

Research published in the Journal of Epidemiology and Community Health suggests that there has been no impact on the number of road accidents following the extension of the M74 in the south of Glasgow. Read the full article.
Revised DH contract will benefit researchers and patients
The Department of Health (DH) and the Health Research Authority (HRA) have been working together to review the standard DH contract for NIHR funded research. From today research funded by an NIHR research programme will be able to receive payments for start-up in advance of ethical approval. This enables more rapid, efficient and streamlined set-up of research and quicker translation of research into patient benefit. Read the full article.